Skip to content

PCOS renamed polyendocrine metabolic ovarian syndrome (PMOS)

scienceMay 12, 202619165

Polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome, or PMOS, after a years-long international consensus. The new label reflects evidence that the condition involves multiple endocrine and metabolic systems rather than being solely a gynecological ovarian disorder and affects roughly 15 percent of women. Clinicians and patient representatives led the effort to correct the misleading PCOS name, which contributed to diagnostic confusion and stigma. Medical leaders say the relabeling should refocus research, broaden diagnostic thinking, and improve targeted treatment and long-term metabolic care.

2 sources